Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7474 433
20 October 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pain relieved without numbness

A way of delivering local anaesthetic so that it blocks pain but does not cause numbness or interfere with motor function has been developed by researchers at Massachusetts General Hospital and Harvard Medical School, Boston.

Anaesthetics usually act by diffusing through cell membranes and blocking sodium channels. But this causes all neurons to be blocked, not just sensory neurons.

The researchers combined QX-314, a normally inactive derivative of the local anaesthetic lidocaine, and capsaicin, the pungent ingredient in chilli peppers, to specifically target pain-sensing neurons.

Capsaicin opens an ion channel called TPRV1, which is only found in pain-sensing neurons. Unlike most anaesthetics, QX-314 has a permanent positive charge and cannot infiltrate lipid membranes to block the excitability of the cell. However, when combined with capsaicin it is able to enter the cell via the TPRV1 ion channel and shut it down. Other types of neurons are not affected since QX-314 remains trapped outside.

The researchers injected QX-314 and capsaicin into the hind paws of rats and found a long-lasting (more than two hours) decrease in their response to painful thermal and mechanical stimuli. Regional injection near the sciatic nerve also produced long-lasting decreases in pain sensitivity without a corresponding motor deficit, say the researchers.

“This strategy for blocking pain should be advantageous for generating pain-restricted local anaesthesia when preserving motor and autonomic responses and non-painful sensations is desirable, such as in childbirth and some dental procedures, as well as treating nociceptor driven chronic pain, such as post-herpetic neuralgia,” they conclude.

However, the researchers point out that they chose capsaicin and QX-314 for initial experiments because they are off-the-shelf reagents with well-characterised properties, but that there may be other reagents better suited to application to humans (Nature 2007;449:607).

Back to Top


©The Pharmaceutical Journal